The High Level Panel on Access to the United Nations Drug released on Wednesday (14) the first report on access to medicines.
According to the document, the healthcare research does not adequately meet the sector's needs because they are focused on diseases that give higher returns and neglect those that generate less profit.
One example cited in the study are antibiotics, which, according to the report, offer little profit on years of research. In these circumstances, experts warn that viruses, bacteria, parasites and drug-resistant fungi can cause 10 million deaths per year worldwide by 2050.
Other examples mentioned examples are infection caused by zika virus and Ebola, both diseases with limited resources for prevention and treatment.
According to the survey, rich and poor countries are affected by the lack of investment in major impact diseases. Lack of access to medicines reaches the entire world population and governments need to invest more money and develop legislation to encourage research in targeted sectors for neglected diseases, the study says.
"New technologies are seldom designed for health conditions that can not deliver high returns, as bacterial infections requiring antibiotics only. rare diseases, which affect comparatively small proportions of the population, does not traditionally have attracted investments, "says the document.
The work of the UN recommends that governments and the pharmaceutical industry to act together to reduce the price of essential medicines, unleashing the cost of research and development of the final value of products.
Among the recommendations, the Panel also proposes that research public funders should require that the knowledge generated from such research be made freely and widely available.
In addition, universities and research institutions that receive public funding should prioritize public health objectives in their practice of patenting and licensing, not the financial return, according to the survey.
The document also calls for more transparency and new strategies for dealing with intellectual property barriers and also states that it is necessary for governments to increase investment in innovation and health technology had answered gaps.
According to the report, stakeholders, including governments, industry sector and institutional funders of health and civil society must test and implement new financing models and public health research, using taxes on financial transactions. and other funding mechanisms.
After publishing report on the subject, the Doctors Without Borders (MSF) supports the recommendations of the Panel and note makes a strong appeal to the Secretary General of the UN, the governments and industry to act in accordance with these recommendations, " with the urgency that the public health issues require. "
"MSF gives welcome the High Panel history report level on Access to Medicines, offering practical recommendations to help overcome the challenges that our medical teams have been facing for decades - leaving empty-handed when drugs, vaccines and tests diagnoses that our patients need not exist or are too expensive. The global scope of the report recognizes that today all countries face challenges when trying to ensure availability and accessibility of medical technologies necessary to health and productive life of the people, "he said in a statement Rohit Malpani, director of policy and analysis of MSF's Access Campaign .
Nenhum comentário:
Postar um comentário